Hi, what are you looking for?
The head grower of one of Canada's leading cannabis producers speaks on being quality-focused from day one and what's next for the brand
In the first substitution study to track individual use over time, researchers found stark drops in use of opioids and other medications
The firm's valuation is rocketing along with most pot stocks, but uncertainty remains if it can better capitalize on both domestic and international markets
In tight competition with High Tide and Fire & Flower, the firm edges ahead in the retail footprint race with its expanding franchise model
In a release of cannabis for medical purposes data, the agency highlights increasingly high daily doses prescribed by a small subset of practitioners